Markers for progression of coronary disease

Pharmacotherapy

Volumn 21, Issue 9 II SUPPL., 2001, Pages

  Bell, D M ^a  

^a WEST VIRGINIA UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN; ANGIOTENSIN 2 RECEPTOR; ARGININE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIPYRIDAMOLE; ENDOTHELIN 1; ENDOTHELIUM DERIVED HYPERPOLARIZING FACTOR; LIPOPROTEIN; NITRIC OXIDE; OXYGEN RADICAL; PROSTACYCLIN; SUPEROXIDE; TETRAHYDROBIOPTERIN; VASOACTIVE AGENT; XANTHINE OXIDASE;

ACTIVE TRANSPORT; ARTERIOSCLEROSIS; BLOOD VESSEL TONE; CARDIOVASCULAR DISEASE; CONFERENCE PAPER; CORONARY ARTERY DISEASE; DISEASE COURSE; DISEASE MARKER; DRUG BIOAVAILABILITY; DRUG MECHANISM; ENDOTHELIUM CELL; FIBRINOLYSIS; HEMOSTASIS; HUMAN; INFLAMMATION; MEMBRANE PERMEABILITY; OXIDATIVE STRESS; PATHOPHYSIOLOGY; RISK FACTOR; THROMBOGENESIS; THROMBOGENICITY; VASOCONSTRICTION; VASODILATATION;

EID: 0034860793     PISSN: 02770008     EISSN: None     Source Type: Journal    
DOI: 10.1592/phco.21.14.190s.34603     Document Type: Conference Paper

References (42)

1. The L-arginine -nitric oxide pathway
2. The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine
3. 2 and prostacyclin
4. Characterisation of endothelium-derived hyperpolarizing factor as a cytochrome P450-derived arachidonic acid metabolite in mammals
5. Endothelins: Molecular biology, biochemistry, pharmacology, physiology and pathophysiology
6. The renin-angiotensin-aldosterone system: A specific target for hypertension management
7. Molecular biology to the rennin-angiotensin system
8. The role of endothelium in cardiovascular homeostasis and diseases
9. Effects of endothelium-derived relaxing factor/nitric oxide on platelet surface glycoproteins
10. Activated platelets induce monocyte chemotactic protein-1 secretion and surface expression of intercellular adhesion molecule-1 on endothelial cells
11. Divergent effects of serotonin on coronary artery dimensions and blood flow in patients with coronary atherosclerosis and control patients
12. Atherosclerosis: An inflammatory disease
13. Endothelial-dependent mechanisms in chronic inflammatory leukocyte recruitment
14. Role of inflammation in the pathogenesis of unstable coronary artery disease
15. Nitric oxide: An endogenous modulator of leukocyte adhesion
16. Homocysteine, EDRF and endothelial function
17. Superoxide anions and hyperoxia inactivate endothelium-derived relaxing factor
18. Aging and endothelial function in normotensive subjects and patients with essential hypertension
19. Cell dysfunction in atherosclerosis and the ischemic manifestations of coronary artery disease
20. The renin-angiotensin system and fibrinolysis
21. The integrated effects of angiotensin 11
22. Menopause is associated with endothelial dysfunction in women
23. Hypertension causes premature aging of endothelial functions in humans
24. Non-invasive detection of endothelial dysfunction in children and adults at risk of atherosclerosis
25. Vascular endothelium: An integrator of pathophysiologic stimuli in atherosclerosis
26. Endothelial cell in physiology and in the pathophysiology of vascular disorders
27. Assessment and treatment of endothelial dysfunction in humans
28. Relationship of atherosclerosis in young men to serum lipoprotein cholesterol concentration and smoking: A preliminary report from the Pathobiological Determinants of Atherosclerosis in Youth (PDAY) Research Group
29. Direct vasoconstriction and endothelium-dependent vasodilatation: Mechanism of acetylcholine effects on coronary flow and arterial diameter in patients with nonstenotic coronary arteries
30. Paradoxical vasoconstriction induced by acetylcholine in atherosclerotic coronary arteries
31. Close relation of endothelial function in the human coronary and peripheral circulations
32. Short-term cholesterol lowering decreases size and severity of perfusion abnormalities by positron emission tomography after dipyridamole in patients with coronary artery disease
33. Impaired vasodilation of forearm resistance vessels in hypercholesterolemic humans
34. Characteristics of flow-mediated brachial artery vasodilation in human subjects
35. Impaired endothelial function in arterial hypertension and hypercholesterolemia: Potential mechanisms and differences
36. Nitric oxide and prostacyclin: Divergence of inhibitory effects on monocyte chemotaxis and adhesion to endothelium in vitro
37. Isolation of nitric oxide synthetase, a calmodulin-requiring enzyme
38. Endothelial dysfunction in cardiovascular diseases: The role of oxidant stress
39. Endothelium-derived hyperpolarizing factor: Identification and mechanisms of action in human subcutaneous resistance arteries
40. Generation of superoxide by purified brain nitric oxide synthase
41. Loss of endothelial pertussis toxin-sensitive G protein function in atherosclerotic porcine coronary arteries
42. Just say NO to ET